Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ugo Testa

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|September 12, 2009
Triterpenoids as new promising anticancer drugsAlessia Petronelli, Gaetano Pannitteri, Ugo Testa
Medicines (Basel, Switzerland)|August 2, 2019
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic ImplicationsUgo Testa, Germana Castelli, Elvira Pelosi
Biomarker Research|February 12, 2014
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignanciesUgo Testa, Elvira Pelosi, Arthur Frankel
Current Oncology (Toronto, Ont.)|January 20, 2023
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted TherapiesUgo Testa, Germana Castelli, Elvira Pelosi
Expert Review of Molecular Diagnostics|December 2, 2022
Clinical value of identifying genes that inhibit hepatocellular carcinomasUgo Testa, Elvira Pelosi, Germana Castelli
Cancers|September 21, 2017
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem CellsGermana Castelli, Elvira Pelosi, Ugo Testa
Medicines (Basel, Switzerland)|August 6, 2020
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsUgo Testa, Elvira Pelosi, Germana Castelli
Biomedicines|October 17, 2020
Genetic Alterations of Metastatic Colorectal CancerUgo Testa, Germana Castelli, Elvira Pelosi
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Cancer stem cell targeted therapiesUgo Testa, Elvira Pelosi, Germana Castelli
Medical Sciences (Basel, Switzerland)|April 14, 2018
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cellsUgo Testa, Elvira Pelosi, Germana Castelli
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|September 12, 2009
Triterpenoids as new promising anticancer drugsAlessia Petronelli, Gaetano Pannitteri, Ugo Testa
Medicines (Basel, Switzerland)|August 2, 2019
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic ImplicationsUgo Testa, Germana Castelli, Elvira Pelosi
Biomarker Research|February 12, 2014
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignanciesUgo Testa, Elvira Pelosi, Arthur Frankel
Current Oncology (Toronto, Ont.)|January 20, 2023
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted TherapiesUgo Testa, Germana Castelli, Elvira Pelosi
Expert Review of Molecular Diagnostics|December 2, 2022
Clinical value of identifying genes that inhibit hepatocellular carcinomasUgo Testa, Elvira Pelosi, Germana Castelli
Cancers|September 21, 2017
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem CellsGermana Castelli, Elvira Pelosi, Ugo Testa
Medicines (Basel, Switzerland)|August 6, 2020
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsUgo Testa, Elvira Pelosi, Germana Castelli
Biomedicines|October 17, 2020
Genetic Alterations of Metastatic Colorectal CancerUgo Testa, Germana Castelli, Elvira Pelosi
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Cancer stem cell targeted therapiesUgo Testa, Elvira Pelosi, Germana Castelli
Medical Sciences (Basel, Switzerland)|April 14, 2018
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cellsUgo Testa, Elvira Pelosi, Germana Castelli
Pageof 17